Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury

Clinical trial NCT06438471 · RECRUITING

Trial details

NCT number: NCT06438471
Sponsor: EicOsis Human Health Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Spinal Cord Injuries Neuropathic Pain Degenerative Disc Disease Spinal Stenosis Spondylosis

Start date: 2026-05-01
Primary completion: 2027-12-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.